All In MedTech

Device Trial Radar · NCT05135403

ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)

Last checked: Nov 20, 2026Latest source record: Sep 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

5,179

Planned (sponsor's estimate)

Start

Nov 20, 2021

Primary completion

Oct 1, 2025

Study completion Oct 1, 2025

Sponsor

Lead sponsor
Kestra Medical Technologies, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Nov 26, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

Active surveillance study using real-world data collected in the ASSURE Patient Registry. Outcome measures are based on analysis of ASSURE Registry data including data recorded by the WCD then annotated by clinical experts in electrophysiology.

Conditions

  • Sudden Cardiac Arrest

Interventions

  • DefibrillationDevice

    External defibrillation from a wearable cardioverter defibrillator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall shock conversion rateTime frame: Up to 3 years

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Washington Medical Center

    Seattle, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.